Rapid Micro Biosystems (RPID) Cash & Equivalents Growth (1y) (2021 - 2026)
Rapid Micro Biosystems (RPID) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -26.57% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 42.78% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -12.13% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.94% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -11.19% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -4.66% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -44.03% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 19.49% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 72.43% |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | -19.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.89% |
| Mar 31, 2026 | 200.00% |
| Dec 31, 2025 | -99.41% |
| Sep 30, 2025 | -14.05% |
| Jun 30, 2025 | 18,233.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 16,811.00% |
| Sep 30, 2024 | 7,248.00% |
| Jun 30, 2024 | -50.00% |
| Mar 31, 2024 | -99.59% |
| Dec 31, 2023 | -50.00% |
| Sep 30, 2023 | -98.84% |
| Jun 30, 2023 | -99.60% |
| Mar 31, 2023 | -60.94% |
| Dec 31, 2022 | -33.33% |
| Sep 30, 2022 | -88.24% |
| Jun 30, 2022 | -50.30% |
| Dec 31, 2021 | -99.00% |